Experimental Pseudomonas aeruginosa pneumonia: Evaluation of the associated inflammatory response

European Respiratory Journal

Volumn 30, Issue 6, 2007, Pages 1167-1172

  Sibila, O ^a   Agusti C ^b   Torres, A ^a,c   Baquero, S ^b   Gando, S ^b   Patron J R ^b   Morato, J G ^b   Goffredo, D H ^b   Bassi, N ^b   Luna, C M ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Experimental pneumonia; Inflammatory response; Interleukin 6; Pseudomonas aeruginosa; Ventilated piglets

Indexed keywords

CYTOKINE; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BRONCHOSCOPY; COLONY FORMING UNIT; CONTROLLED STUDY; HISTOPATHOLOGY; INOCULATION; LABORATORY TEST; LUNG LAVAGE; LUNG PARENCHYMA; NONHUMAN; PIGLET; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSEUDOMONAS AERUGINOSA;

ANIMALS; BRONCHOALVEOLAR LAVAGE; CYTOKINES; INFLAMMATION; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; SWINE;

EID: 38849207854     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00053607     Document Type: Article

References (24)

1. Bodí M, Rodríguez A, Solé-Violán J, et al. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival. Clin Infect Dis 2005; 41: 1709-1716.
2. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165: 867-903.
3. Montón C, Torres A, El-Ebiary M, Filella X, Xaubet A, de la Bellacasa JP. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study. Crit Care Med 1999; 27: 1745-1753.
4. Schütte H, Lohmeyer J, Rosseau S, et al. Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J 1996; 9: 1858-1867.
5. Fernández-Serrano S, Dorca J, Coromines M, Carratalá J, Gudiol F, Manresa F. Molecular inflammatory responses measured in blood of patients with severe communityacquired pneumonia. Clin Diagn Lab Immunol 2003; 10: 813-820.
6. Ioanas M, Ferrer M, Cavalcanti M, et al. Causes and predictors of nonresponse to treatment of the intensive care unit-acquired pneumonia. Crit Care Med 2004; 32: 938-945.
7. Marquette CH, Wermert D, Wallet F, Copin MC, Tonnel AB. Characterization of an animal model of ventilator-acquired pneumonia. Chest 1999; 115: 200-209.
8. Wermert D, Marquette CH, Copin MC, et al. Influence of pulmonary bacteriology and histology on the yield of diagnostic procedures in ventilator-acquired pneumonia. Am J Respir Crit Care Med 1998; 158: 139-147.
9. Goldstein I, Bughalo MT, Marquette CH, et al. Mechanical ventilation-induced air-space enlargement during experimental pneumonia in piglets. Am J Respir Crit Care Med 2001; 163: 958-964.
10. Goldstein I, Wallet F, Nicolas-Robin A, Ferrari F, Marquette CH, Rouby JJ. Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets. Am J Respir Crit Care Med 2002; 166: 1375-1381.
11. Elman M, Goldstein I, Marquette CH, et al. Influence of lung aeration on pulmonary concentrations of nebulized and intravenous amikacin in ventilated piglets with severe bronchopneumonia. Anesthesiology 2002; 97: 199-206.
12. Ferrari F, Goldstein I, Nieszkowszka A, et al. Lack of lung tissue and systemic accumulation after consecutive daily aerosols of amikacin in ventilated piglets with healthy lungs. Anesthesiology 2003; 98: 1016-1019.
13. Tonnellier M, Ferrari F, Goldstein I, Sartorius A, Marquette CH, Rouby JJ. Intravenous versus nebulized ceftazidime in ventilated piglets with and without experimental bronchopneumonia: comparative effects of helium and nitrogen. Anesthesiology 2005; 102: 995-1000.
14. Luna CM, Baquero S, Gando S, et al. Experimental severe Pseudomonas aeruginosa pneumonia and antibiotic therapy in piglets receiving mechanical ventilation. Chest 2007; 132: 523-531.
15. Rossi A, Polese G, Brandi G, Conti G. Intrinsic positive end-expiratory pressure (PEEPi). Intensive Care Med 1995; 21: 522-536.
16. El-Ebiary M, Torres A, González J, et al. Quantitative cultures of endotracheal aspirates for the diagnosis of ventilator-associated pneumonia. Am Rev Respir Dis 1993; 148: 1552-1557.
17. Balows A, Hausler WJJ, eds. Manual of Clinical Microbiology. 5th Edn. Washington, American Society for Microbiology, 1991.
18. Marquette CH, Copin MC, Wallet F, et al. Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med 1995; 151: 1878-1888.
19. US Department of Health and Human Services. Guide for the Care and Use of Laboratory Animals. National Institute of Health Publication No. 93-23, revised 1985.
20. Meduri GU, Eltorky M, Winer-Muram HT. The fibroproliferative phase of late adult respiratory distress syndrome. Semin Respir Infect 1995; 10: 154-175.
21. Dehoux MS, Boutten A, Ostinelli J, et al. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1994; 150: 710-716.
22. Bauer TT, Montón C, Torres A, et al. Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax 2000; 55: 46-52.
23. Glynn P, Coakley R, Kilgallen I, Murphy N, O'Neill S. Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax 1999; 54: 51-55.
24. Antunes G, Evans SA, Lordan JL, Frew AJ. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity. Eur Respir J 2002; 20: 990-995.